Yale University

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.

TitleTrends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
Publication TypeJournal Article
Year of Publication2009
AuthorsDeeks, Steven G., Stephen J. Gange, Mari M. Kitahata, Michael S. Saag, Amy C. Justice, Robert S. Hogg, Joseph J. Eron, John T. Brooks, Sean B. Rourke, John M. Gill, Ronald J. Bosch, Constance A. Benson, Ann C. Collier, Jeffrey N. Martin, Marina B. Klein, Lisa P. Jacobson, Benigno Rodriguez, Timothy R. Sterling, Gregory D. Kirk, Sonia Napravnik, Anita R. Rachlis, Liviana M. Calzavara, Michael A. Horberg, Michael J. Silverberg, Kelly A. Gebo, Margot B. Kushel, James J. Goedert, Rosemary G. McKaig, and Richard D. Moore
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume49
Issue10
Pagination1582-90
Date Published2009 Nov 15
ISSN1537-6591
KeywordsAdult, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Cohort Studies, Drug Resistance, Multiple, Viral, Female, HIV, HIV Infections, Humans, Male, Middle Aged, Models, Statistical, North America, Survival Analysis, Treatment Failure, Viral Load
AbstractAlthough combination antiretroviral therapy continues to evolve, with potentially more effective options emerging each year, the ability of therapy to prevent multiple regimen failure and mortality in clinical practice remains poorly defined.
DOI10.1086/644768
Alternate JournalClin. Infect. Dis.

External Links